Working… Menu

Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00666991
Recruitment Status : Completed
First Posted : April 25, 2008
Last Update Posted : February 27, 2014
University of Kansas Medical Center
Beckloff Associates, Inc.
Information provided by (Responsible Party):
CritiTech, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 2013
Actual Study Completion Date : May 2013